首页 | 本学科首页   官方微博 | 高级检索  
     检索      


R&D innovation and the value of cash in the biotech industry
Authors:Bixia Xu
Institution:School of Business & Economics, Wilfrid Laurier University, Waterloo, Ontario, Canada N2L 3C5
Abstract:This study investigates how the market pricing of an additional dollar of cash held by biotech firms is conditional upon the industry's typical performance, R&D innovation. Under the proposed R&D innovation regime, I find i) an additional dollar of cash is priced higher if held by a firm with higher R&D innovation; ii) the role of R&D innovation is asymmetric depending on whether R&D activities move the drug discovery and development forward or backward; and iii) R&D innovation also differentiates the association between investment opportunities and value of cash observed by prior studies.
Keywords:Cash reserves  R&  D innovation  Market pricing of cash reserves  Investment opportunities
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号